Clinical Trial Update: Neuromuscular Magnetic Stimulation in ALS Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neuromuscular magnetic stimulation in patients with amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED